Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL28238218 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL730594 | 1.00 | — | — | |
| Cysteine SCHEMBL1573764 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL18160 | 1.00 | — | — | |
| Cysteine SCHEMBL1573765 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL17394843 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL16894009 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL16894007 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL50241 | 1.00 | — | — | |
| Cysteine SCHEMBL7610984 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746360-B2 | Eukaryotic cell transfection systems and related methods | WURM FLORIAN M (CH) | 2023-09-05 | — | — | US | claimed |
| WO-2023163559-A1 | STEM CELL CULTURE METHOD USING SERUM-FREE MEDIUM | 주식회사 강스템바이오텍 | 2023-08-31 | — | — | WO | claimed |
| CN-114892444-B | Paper-based mulching film and preparation method and application thereof | 南京林业大学 | 2023-05-09 | — | — | CN | claimed |
| CN-114892444-A | Paper-based mulching film and preparation method and application thereof | 南京林业大学 | 2022-08-12 | — | — | CN | claimed |
| EP-3924463-A1 | NOVEL EUKARYOTIC CELL TRANSFECTION SYSTEMS AND RELATED METHODS | Excellgene SA (CH) | 2021-12-22 | — | — | EP | claimed |
| CN-108265021-B | Leech cell in-vitro culture medium and culture method thereof | 苏州至汇生物科技有限公司 | 2021-08-27 | — | — | CN | claimed |
| CN-107106459-B | Pharmaceutical composition for improving skin condition comprising cell culture medium, epidermal growth factor and bovine serum albumin | 韩国比奥科斯全球公司 | 2021-06-22 | — | — | CN | claimed |
| US-20210145929-A1 | AAV COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE | NIGHTSTARX LIMITED (GB) | 2021-05-20 | — | — | US | claimed |
| US-10801009-B2 | Cosmetic composition for improving condition of skin, containing cell culture medium, epidermal growth factor and bovine serum albumin | BIOCOZ GLOBAL KOREA CORP. (KR) | 2020-10-13 | — | — | US | claimed |
| WO-2020165656-A1 | NOVEL EUKARYOTIC CELL TRANSFECTION SYSTEMS AND RELATED METHODS | EXCELLGENE S.A. (CH) | 2020-08-20 | — | — | WO | claimed |
| CN-108728404-A | Ox live body or the method for in vitro oocyte collection IVF Embryos culture | 天津博裕力牧科技有限公司 | 2018-11-02 | — | — | CN | claimed |
| CN-104928251-B | A kind of cultivating system of inducing pluripotent stem cells | 中国科学院动物研究所 | 2018-06-26 | — | — | CN | claimed |
| US-9943545-B2 | Stem cell culture media and methods of enhancing cell survival | FATE THERAPEUTICS, INC. (US) | 2018-04-17 | — | — | US | claimed |
| US-20170355952-A1 | COSMETIC COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING CELL CULTURE MEDIUM, EPIDERMAL GROWTH FACTOR AND BOVINE SERUM ALBUMIN | BIOCOZ GLOBAL KOREA CORP. (KR) | 2017-12-14 | — | — | US | claimed |
| CN-107163037-A | A kind of common amorphous substance of Lurasidone HCl amino acid | 中国药科大学 | 2017-09-15 | — | — | CN | claimed |
| US-9029119-B2 | Composition for the cultivation of sophisticated bacteria | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) | 2015-05-12 | — | — | US | claimed |
| EP-2671945-A1 | METHOD FOR CULTURING HUMAN PLURIPOTENT STEM CELLS | National Institute of Biomedical Innovation (JP) | 2013-12-11 | — | — | EP | claimed |
| US-20130309768-A1 | METHOD FOR CULTURING HUMAN PLURIPOTENT STEM CELLS | NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION (JP) | 2013-11-21 | — | — | US | claimed |
| WO-2013032052-A1 | METHOD FOR PREPARING A BASIC CULTURE MEDIUM FOR MESENCHYMAL STEM CELLS, BASIC CULTURE MEDIUM FOR MESENCHYMAL STEM CELLS, AND CELL THERAPEUTIC AGENT CULTURED AND DIFFERENTIATED USING SAME | 세원셀론텍(주) (KR) | 2013-03-07 | — | — | WO | claimed |
| US-20110070627-A1 | Composition for the cultivation of sophisticated bacteria | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) | 2011-03-24 | — | — | US | claimed |